カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の粘膜下注射剤市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global Submucosal Injection Agent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23SM7985）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23SM7985
■ 発行日：2023年9月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：99
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の粘膜下注射剤市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界の粘膜下注射剤の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の粘膜下注射剤市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 粘膜下注射剤の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

粘膜下注射剤市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・シリンジ式、アンプル式

用途別セグメント
・病院、外来手術センター、専門診療所

主要な市場プレーヤー
・Seikagaku、Ovesco Endoscopy、GI Supply、Cosmo Pharmaceuticals、Boston Scientific、The Standard、Micro-Tech Endoscopy、EndoClot Plus

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、粘膜下注射剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な粘膜下注射剤メーカーの企業概要、2019年～2022年までの粘膜下注射剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な粘膜下注射剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別粘膜下注射剤の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの粘膜下注射剤のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での粘膜下注射剤市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および粘膜下注射剤の産業チェーンを掲載しています。
・第14、15章では、粘膜下注射剤の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 粘膜下注射剤の概要
– タイプ別分析（2018年vs2022年vs2029年）：シリンジ式、アンプル式
– 用途別分析（2018年vs2022年vs2029年）：病院、外来手術センター、専門診療所
– 世界の粘膜下注射剤市場規模・予測
– 世界の粘膜下注射剤生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Seikagaku、Ovesco Endoscopy、GI Supply、Cosmo Pharmaceuticals、Boston Scientific、The Standard、Micro-Tech Endoscopy、EndoClot Plus
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：シリンジ式、アンプル式
・用途別分析2018年-2029年：病院、外来手術センター、専門診療所
・粘膜下注射剤の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・粘膜下注射剤のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・粘膜下注射剤のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・粘膜下注射剤の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・粘膜下注射剤の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Submucosal Injection Agent
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Submucosal Injection Agent Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Syringe Type
1.3.3 Ampoule Type
1.4 Market Analysis by Application
1.4.1 Overview: Global Submucosal Injection Agent Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Centers
1.4.4 Specialty Clinics
1.5 Global Submucosal Injection Agent Market Size & Forecast
1.5.1 Global Submucosal Injection Agent Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Submucosal Injection Agent Sales Quantity (2018-2029)
1.5.3 Global Submucosal Injection Agent Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Seikagaku
2.1.1 Seikagaku Details
2.1.2 Seikagaku Major Business
2.1.3 Seikagaku Submucosal Injection Agent Product and Services
2.1.4 Seikagaku Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Seikagaku Recent Developments/Updates
2.2 Ovesco Endoscopy
2.2.1 Ovesco Endoscopy Details
2.2.2 Ovesco Endoscopy Major Business
2.2.3 Ovesco Endoscopy Submucosal Injection Agent Product and Services
2.2.4 Ovesco Endoscopy Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Ovesco Endoscopy Recent Developments/Updates
2.3 GI Supply
2.3.1 GI Supply Details
2.3.2 GI Supply Major Business
2.3.3 GI Supply Submucosal Injection Agent Product and Services
2.3.4 GI Supply Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GI Supply Recent Developments/Updates
2.4 Cosmo Pharmaceuticals
2.4.1 Cosmo Pharmaceuticals Details
2.4.2 Cosmo Pharmaceuticals Major Business
2.4.3 Cosmo Pharmaceuticals Submucosal Injection Agent Product and Services
2.4.4 Cosmo Pharmaceuticals Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Cosmo Pharmaceuticals Recent Developments/Updates
2.5 Boston Scientific
2.5.1 Boston Scientific Details
2.5.2 Boston Scientific Major Business
2.5.3 Boston Scientific Submucosal Injection Agent Product and Services
2.5.4 Boston Scientific Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Boston Scientific Recent Developments/Updates
2.6 The Standard
2.6.1 The Standard Details
2.6.2 The Standard Major Business
2.6.3 The Standard Submucosal Injection Agent Product and Services
2.6.4 The Standard Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 The Standard Recent Developments/Updates
2.7 Micro-Tech Endoscopy
2.7.1 Micro-Tech Endoscopy Details
2.7.2 Micro-Tech Endoscopy Major Business
2.7.3 Micro-Tech Endoscopy Submucosal Injection Agent Product and Services
2.7.4 Micro-Tech Endoscopy Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Micro-Tech Endoscopy Recent Developments/Updates
2.8 EndoClot Plus
2.8.1 EndoClot Plus Details
2.8.2 EndoClot Plus Major Business
2.8.3 EndoClot Plus Submucosal Injection Agent Product and Services
2.8.4 EndoClot Plus Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 EndoClot Plus Recent Developments/Updates
3 Competitive Environment: Submucosal Injection Agent by Manufacturer
3.1 Global Submucosal Injection Agent Sales Quantity by Manufacturer (2018-2023)
3.2 Global Submucosal Injection Agent Revenue by Manufacturer (2018-2023)
3.3 Global Submucosal Injection Agent Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Submucosal Injection Agent by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Submucosal Injection Agent Manufacturer Market Share in 2022
3.4.2 Top 6 Submucosal Injection Agent Manufacturer Market Share in 2022
3.5 Submucosal Injection Agent Market: Overall Company Footprint Analysis
3.5.1 Submucosal Injection Agent Market: Region Footprint
3.5.2 Submucosal Injection Agent Market: Company Product Type Footprint
3.5.3 Submucosal Injection Agent Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Submucosal Injection Agent Market Size by Region
4.1.1 Global Submucosal Injection Agent Sales Quantity by Region (2018-2029)
4.1.2 Global Submucosal Injection Agent Consumption Value by Region (2018-2029)
4.1.3 Global Submucosal Injection Agent Average Price by Region (2018-2029)
4.2 North America Submucosal Injection Agent Consumption Value (2018-2029)
4.3 Europe Submucosal Injection Agent Consumption Value (2018-2029)
4.4 Asia-Pacific Submucosal Injection Agent Consumption Value (2018-2029)
4.5 South America Submucosal Injection Agent Consumption Value (2018-2029)
4.6 Middle East and Africa Submucosal Injection Agent Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Submucosal Injection Agent Sales Quantity by Type (2018-2029)
5.2 Global Submucosal Injection Agent Consumption Value by Type (2018-2029)
5.3 Global Submucosal Injection Agent Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Submucosal Injection Agent Sales Quantity by Application (2018-2029)
6.2 Global Submucosal Injection Agent Consumption Value by Application (2018-2029)
6.3 Global Submucosal Injection Agent Average Price by Application (2018-2029)
7 North America
7.1 North America Submucosal Injection Agent Sales Quantity by Type (2018-2029)
7.2 North America Submucosal Injection Agent Sales Quantity by Application (2018-2029)
7.3 North America Submucosal Injection Agent Market Size by Country
7.3.1 North America Submucosal Injection Agent Sales Quantity by Country (2018-2029)
7.3.2 North America Submucosal Injection Agent Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Submucosal Injection Agent Sales Quantity by Type (2018-2029)
8.2 Europe Submucosal Injection Agent Sales Quantity by Application (2018-2029)
8.3 Europe Submucosal Injection Agent Market Size by Country
8.3.1 Europe Submucosal Injection Agent Sales Quantity by Country (2018-2029)
8.3.2 Europe Submucosal Injection Agent Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Submucosal Injection Agent Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Submucosal Injection Agent Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Submucosal Injection Agent Market Size by Region
9.3.1 Asia-Pacific Submucosal Injection Agent Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Submucosal Injection Agent Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Submucosal Injection Agent Sales Quantity by Type (2018-2029)
10.2 South America Submucosal Injection Agent Sales Quantity by Application (2018-2029)
10.3 South America Submucosal Injection Agent Market Size by Country
10.3.1 South America Submucosal Injection Agent Sales Quantity by Country (2018-2029)
10.3.2 South America Submucosal Injection Agent Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Submucosal Injection Agent Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Submucosal Injection Agent Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Submucosal Injection Agent Market Size by Country
11.3.1 Middle East & Africa Submucosal Injection Agent Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Submucosal Injection Agent Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Submucosal Injection Agent Market Drivers
12.2 Submucosal Injection Agent Market Restraints
12.3 Submucosal Injection Agent Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Submucosal Injection Agent and Key Manufacturers
13.2 Manufacturing Costs Percentage of Submucosal Injection Agent
13.3 Submucosal Injection Agent Production Process
13.4 Submucosal Injection Agent Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Submucosal Injection Agent Typical Distributors
14.3 Submucosal Injection Agent Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Submucosal Injection Agent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Submucosal Injection Agent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Seikagaku Basic Information, Manufacturing Base and Competitors
Table 4. Seikagaku Major Business
Table 5. Seikagaku Submucosal Injection Agent Product and Services
Table 6. Seikagaku Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Seikagaku Recent Developments/Updates
Table 8. Ovesco Endoscopy Basic Information, Manufacturing Base and Competitors
Table 9. Ovesco Endoscopy Major Business
Table 10. Ovesco Endoscopy Submucosal Injection Agent Product and Services
Table 11. Ovesco Endoscopy Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Ovesco Endoscopy Recent Developments/Updates
Table 13. GI Supply Basic Information, Manufacturing Base and Competitors
Table 14. GI Supply Major Business
Table 15. GI Supply Submucosal Injection Agent Product and Services
Table 16. GI Supply Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GI Supply Recent Developments/Updates
Table 18. Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Cosmo Pharmaceuticals Major Business
Table 20. Cosmo Pharmaceuticals Submucosal Injection Agent Product and Services
Table 21. Cosmo Pharmaceuticals Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Cosmo Pharmaceuticals Recent Developments/Updates
Table 23. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 24. Boston Scientific Major Business
Table 25. Boston Scientific Submucosal Injection Agent Product and Services
Table 26. Boston Scientific Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Boston Scientific Recent Developments/Updates
Table 28. The Standard Basic Information, Manufacturing Base and Competitors
Table 29. The Standard Major Business
Table 30. The Standard Submucosal Injection Agent Product and Services
Table 31. The Standard Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. The Standard Recent Developments/Updates
Table 33. Micro-Tech Endoscopy Basic Information, Manufacturing Base and Competitors
Table 34. Micro-Tech Endoscopy Major Business
Table 35. Micro-Tech Endoscopy Submucosal Injection Agent Product and Services
Table 36. Micro-Tech Endoscopy Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Micro-Tech Endoscopy Recent Developments/Updates
Table 38. EndoClot Plus Basic Information, Manufacturing Base and Competitors
Table 39. EndoClot Plus Major Business
Table 40. EndoClot Plus Submucosal Injection Agent Product and Services
Table 41. EndoClot Plus Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. EndoClot Plus Recent Developments/Updates
Table 43. Global Submucosal Injection Agent Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 44. Global Submucosal Injection Agent Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global Submucosal Injection Agent Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 46. Market Position of Manufacturers in Submucosal Injection Agent, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and Submucosal Injection Agent Production Site of Key Manufacturer
Table 48. Submucosal Injection Agent Market: Company Product Type Footprint
Table 49. Submucosal Injection Agent Market: Company Product Application Footprint
Table 50. Submucosal Injection Agent New Market Entrants and Barriers to Market Entry
Table 51. Submucosal Injection Agent Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Submucosal Injection Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 53. Global Submucosal Injection Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 54. Global Submucosal Injection Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global Submucosal Injection Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global Submucosal Injection Agent Average Price by Region (2018-2023) & (US$/Unit)
Table 57. Global Submucosal Injection Agent Average Price by Region (2024-2029) & (US$/Unit)
Table 58. Global Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Global Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Global Submucosal Injection Agent Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global Submucosal Injection Agent Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global Submucosal Injection Agent Average Price by Type (2018-2023) & (US$/Unit)
Table 63. Global Submucosal Injection Agent Average Price by Type (2024-2029) & (US$/Unit)
Table 64. Global Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 65. Global Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 66. Global Submucosal Injection Agent Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global Submucosal Injection Agent Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global Submucosal Injection Agent Average Price by Application (2018-2023) & (US$/Unit)
Table 69. Global Submucosal Injection Agent Average Price by Application (2024-2029) & (US$/Unit)
Table 70. North America Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 71. North America Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 72. North America Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 73. North America Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 74. North America Submucosal Injection Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 75. North America Submucosal Injection Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 76. North America Submucosal Injection Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America Submucosal Injection Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Europe Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Europe Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 81. Europe Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 82. Europe Submucosal Injection Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 83. Europe Submucosal Injection Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 84. Europe Submucosal Injection Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Submucosal Injection Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 87. Asia-Pacific Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 88. Asia-Pacific Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 89. Asia-Pacific Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 90. Asia-Pacific Submucosal Injection Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 91. Asia-Pacific Submucosal Injection Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 92. Asia-Pacific Submucosal Injection Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific Submucosal Injection Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 95. South America Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 96. South America Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 97. South America Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 98. South America Submucosal Injection Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 99. South America Submucosal Injection Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 100. South America Submucosal Injection Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America Submucosal Injection Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 103. Middle East & Africa Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 104. Middle East & Africa Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Middle East & Africa Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Middle East & Africa Submucosal Injection Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 107. Middle East & Africa Submucosal Injection Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 108. Middle East & Africa Submucosal Injection Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa Submucosal Injection Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 110. Submucosal Injection Agent Raw Material
Table 111. Key Manufacturers of Submucosal Injection Agent Raw Materials
Table 112. Submucosal Injection Agent Typical Distributors
Table 113. Submucosal Injection Agent Typical Customers
List of Figures
Figure 1. Submucosal Injection Agent Picture
Figure 2. Global Submucosal Injection Agent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Submucosal Injection Agent Consumption Value Market Share by Type in 2022
Figure 4. Syringe Type Examples
Figure 5. Ampoule Type Examples
Figure 6. Global Submucosal Injection Agent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Submucosal Injection Agent Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Examples
Figure 9. Ambulatory Surgical Centers Examples
Figure 10. Specialty Clinics Examples
Figure 11. Global Submucosal Injection Agent Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Submucosal Injection Agent Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Submucosal Injection Agent Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Submucosal Injection Agent Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Submucosal Injection Agent Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Submucosal Injection Agent Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Submucosal Injection Agent by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Submucosal Injection Agent Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Submucosal Injection Agent Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Submucosal Injection Agent Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Submucosal Injection Agent Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Submucosal Injection Agent Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Submucosal Injection Agent Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Submucosal Injection Agent Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Submucosal Injection Agent Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Submucosal Injection Agent Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Submucosal Injection Agent Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Submucosal Injection Agent Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Submucosal Injection Agent Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Submucosal Injection Agent Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Submucosal Injection Agent Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Submucosal Injection Agent Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Submucosal Injection Agent Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Submucosal Injection Agent Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Submucosal Injection Agent Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Submucosal Injection Agent Consumption Value Market Share by Region (2018-2029)
Figure 53. China Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Submucosal Injection Agent Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Submucosal Injection Agent Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Submucosal Injection Agent Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Submucosal Injection Agent Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Submucosal Injection Agent Market Drivers
Figure 74. Submucosal Injection Agent Market Restraints
Figure 75. Submucosal Injection Agent Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Submucosal Injection Agent in 2022
Figure 78. Manufacturing Process Analysis of Submucosal Injection Agent
Figure 79. Submucosal Injection Agent Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の内視鏡ビデオレコーダー市場2023年：企業・地域・タイプ・用途別分析
  • 世界のデゾシン注射市場2023年：企業・地域・タイプ・用途別分析
  • 世界のヨード馬尿酸ナトリウム[131I]注射剤市場2023年：企業・地域・タイプ・用途別分析
  • 世界の注射用塩酸レミフェンタニル市場2023年：企業・地域・タイプ・用途別分析
  • 世界の内視鏡用吸入器市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23SM7985 )"世界の粘膜下注射剤市場2023年：企業・地域・タイプ・用途別分析" (英文：Global Submucosal Injection Agent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。